Mechanism of Action: Cytochrome P450 1A2 Inducers
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 1A2 Inducers
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 078115-003 | Mar 31, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Umedica | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216594-001 | Aug 18, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Unichem | CARBAMAZEPINE | carbamazepine | TABLET;ORAL | 213284-001 | Aug 22, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Taro | CARBAMAZEPINE | carbamazepine | TABLET;ORAL | 074649-001 | Oct 3, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |